PROTEGO Study Protocol: A Cluster Randomised Crossover Trial of Vernix Caseosa Retention for Primary Prevention of Atopic Dermatitis
0 citations
Abstract
Summary PROTEGO is a Chilean cluster‐randomised crossover trial of vernix caseosa retention to prevent atopic dermatitis. 1383 mother‐infant dyads will be enrolled and followed for atopic dermatitis until 12 months.
// Source
Authors: Arturo Borzutzky, Carolina Cabalín, Juan Pablo Fraga, Jorge Fabres, Alberto Toso, Marcelo Farías, Maria-Laura Cossio, María José Escalante, Paula Fajuri, Maite Rojas-McKenzie, Magdalena Sande, Rosario Willatt, Carolina Barrientos, Robert J. Boyle
Institutions: Université de Montréal, Pontificia Universidad Católica de Chile, Public Health England